BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 227 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $833,000 | -0.8% | 5,512 | -4.5% | 0.00% | 0.0% |
| Q2 2022 | $840,000 | +13.4% | 5,771 | -7.7% | 0.00% | 0.0% |
| Q1 2022 | $741,000 | -8.2% | 6,253 | +6.8% | 0.00% | 0.0% |
| Q4 2021 | $807,000 | +19.4% | 5,856 | +20.3% | 0.00% | 0.0% |
| Q3 2021 | $676,000 | +39.4% | 4,867 | -2.7% | 0.00% | +100.0% |
| Q2 2021 | $485,000 | +60.6% | 5,000 | +13.0% | 0.00% | 0.0% |
| Q1 2021 | $302,000 | -20.9% | 4,426 | -0.8% | 0.00% | 0.0% |
| Q4 2020 | $382,000 | +24.8% | 4,462 | -5.2% | 0.00% | 0.0% |
| Q3 2020 | $306,000 | -7.3% | 4,707 | +4.2% | 0.00% | 0.0% |
| Q2 2020 | $330,000 | – | 4,519 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $108,659,000 | 54.35% |
| Knoll Capital Management, LLC | 749,815 | $38,593,000 | 29.33% |
| VHCP Management II, LLC | 1,138,075 | $58,577,000 | 17.14% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,021,392 | $52,571,000 | 11.19% |
| Aisling Capital Management LP | 274,513 | $14,129,000 | 10.76% |
| Foresite Capital Management IV, LLC | 518,560 | $26,690,000 | 9.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 844,266 | $43,454,000 | 5.81% |
| ACUTA CAPITAL PARTNERS, LLC | 206,000 | $10,603,000 | 5.04% |
| ARS Investment Partners, LLC | 464,127 | $23,889,000 | 4.32% |
| Cormorant Asset Management, LP | 1,100,000 | $56,617,000 | 3.83% |